Headlands Technologies’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38,447
| Closed | -$55.4K | – | 1287 |
|
|
2025
Q1 | $55.4K | Sell |
38,447
-216,619
| -85% | -$312K | 0.01% | 696 |
|
|
2024
Q4 | $561K | Buy |
255,066
+90,522
| +55% | +$199K | 0.06% | 324 |
|
|
2024
Q3 | $271K | Sell |
164,544
-111,716
| -40% | -$184K | 0.03% | 450 |
|
|
2024
Q2 | $613K | Buy |
+276,260
| New | +$613K | 0.07% | 242 |
|
|
2024
Q1 | – | Sell |
-3,208
| Closed | -$9.59K | – | 1323 |
|
|
2023
Q4 | $9.59K | Buy |
+3,208
| New | +$9.59K | ﹤0.01% | 762 |
|
|
2023
Q3 | – | Sell |
-2,110
| Closed | -$2.93K | – | 1009 |
|
|
2023
Q2 | $2.93K | Buy |
+2,110
| New | +$2.93K | ﹤0.01% | 704 |
|